In the realm of medical diagnostics, technological advancements are often the catalysts that reshape the landscape. A prime example of this phenomenon is the rapid evolution of minimal residual disease (MRD) testing, a technique used to detect and quantify the small number of cancer cells that remain in a patient's body after treatment.